11 research outputs found
What is in your cup of tea? DNA Verity Test to characterize black and green commercial teas
In this study, we used several molecular techniques to develop a fast and reliable protocol (DNA Verity Test, DVT) for the characterization and confirmation of the species or taxa present in herbal infusions. As a model plant for this protocol, Camellia sinensis, a traditional
tea plant, was selected due to the following reasons: its historical popularity as a (healthy) beverage, its high selling value, the importation of barely recognizable raw product (i.e., crushed), and the scarcity of studies concerning adulterants or contamination. The DNA
Verity Test includes both the sequencing of DNA barcoding markers and genotyping of labeled-PCR DNA barcoding fragments for each sample analyzed. This protocol (DVT) was successively applied to verify the authenticity of 32 commercial teas (simple or admixture),
and the main results can be summarized as follows: (1) the DVT protocol is suitable to detect adulteration in tea matrices (contaminations or absence of certified ingredients), and the method can be exported for the study of other similar systems; (2) based on the BLAST
analysis of the sequences of rbcL+matK±rps7-trnV(GAC) chloroplast markers, C. sinensis can be taxonomically characterized; (3) rps7-trnV(GAC) can be employed to discriminate C. sinensis from C. pubicosta; (4) ITS2 is not an ideal DNA barcode for tea samples, reflecting
potential incomplete lineage sorting and hybridization/introgression phenomena in C. sinensis taxa; (5) the genotyping approach is an easy, inexpensive and rapid pre-screening method to detect anomalies in the tea templates using the trnH(GUG)-psbA barcoding
marker; (6) two herbal companies provided no authentic products with a contaminant or without some of the listed ingredients; and (7) the leaf matrices present in some teabags could be constituted using an admixture of different C. sinensis haplotypes and/or allied species
(C. pubicosta)
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells.
mTOR kinase and the A isoform of lactate dehydrogenase (LDH-A) are key players controlling the metabolic characteristics of cancer cells. By using cultured human breast cells as a "metabolic tumor" model, we attempted to explore the correlation between these two factors. "Metabolic tumors" are defined as neoplastic conditions frequently associated with features of the metabolic syndrome, such as hyper-insulinemia and hyper-glycemia. MCF-7 cells (a well differentiated carcinoma) and MCF-10A cells (a widely used model for studying normal breast cell transformation) were used in this study. These cells were exposed to known factors triggering mTOR activation. In both treated cultures, we evaluated the link between mTOR kinase activity and the level of LDH expression / function. Furthermore, we elaborated the metabolic changes produced in cells by the mTOR-directed LDH-A up-regulation. Interestingly, we observed that in the non-neoplastic MCF-10A culture, mTOR-directed up-regulation of LDH-A was followed by a reprogramming of cell metabolism, which showed an increased dependence on glycolysis rather than on oxidative reactions. As a consequence, lactate production appeared to be enhanced and cells began to display increased self-renewal and clonogenic power: signals suggestive of neoplastic change. Enhanced clonogenicity of cells was abolished by rapamycin treatment, and furthermore heavily reduced by LDH enzymatic inhibition. These results highlighted a mechanistic link between metabolic alterations and tumorigenesis, whereby suggesting LDH inhibition as a possible chemo-preventive measure to target the metabolic alterations driving neoplastic change
Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir
Altered energy metabolism is a biochemical fingerprint of cancer cells, widely recognized as one of the "hallmarks of cancer". Cancer cells show highly increased rates of glucose uptake and glycolysis, after which the resulting pyruvate is converted to lactate. The maintenance of this metabolic asset is warranted by lactate dehydrogenase A (LDH-A) and for this reason the development of novel LDH-targeted anticancer therapeutics is underway. However, possible interference in cancer cell metabolism could also arise from cAMP signaling pathway, which could be activated by either oncogenic induction or exogenously, as a result of microenvironment-derived stimuli, increasing cellular cAMP levels. This study aimed at evaluating the impact of activated cAMP signaling pathway on the efficacy of an LDH-targeted anticancer approach
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes
Geraniol is a natural monoterpene showing anti-inflammatory, antioxidant, neuroprotective and anticancer effects. No pharmacokinetic and bioavailability data on geraniol are currently available. We therefore performed a systematic study to identify the permeation properties of geraniol across intestinal cells, and its pharmacokinetics and bioavailability after intravenous and oral administration to rats. In addition, we systematically investigated the potential hepatotoxic effects of high doses of geraniol on hepatic phase I, phase II and antioxidant enzymatic activities and undertook a hematochemical analysis on mice. Permeation studies performed via HPLC evidenced geraniol permeability coefficients across an in vitro model of the human intestinal wall for apical to basolateral and basolateral to apical transport of 13.10 ± 2.3 Ã\u97 10-3and 2.1 ± 0.1·Ã\u97 10-3cm/min, respectively. After intravenous administration of geraniol to rats (50 mg/kg), its concentration in whole blood (detected via HPLC) decreased following an apparent pseudo-first order kinetics with a half-life of 12.5 ± 1.5 min. The absolute bioavailability values of oral formulations (50 mg/kg) of emulsified geraniol or fiber-adsorbed geraniol were 92 and 16%, respectively. Following emulsified oral administration, geraniol amounts in the cerebrospinal fluid of rats ranged between 0.72 ± 0.08 μg/mL and 2.6 ± 0.2 μg/mL within 60 min. Mice treated with 120 mg/kg of geraniol for 4 weeks showed increased anti-oxidative defenses with no signs of liver toxicity. CYP450 enzyme activities appeared only slightly affected by the high dosage of geraniol
Correction: What is in your cup of tea? DNA Verity Test to characterize black and green commercial teas(PLoS ONE (2017) 12:5 (e0178262) DOI: 10.1371/journal.pone.0178262)
In this study, we used several molecular techniques to develop a fast and reliable protocol
(DNA Verity Test, DVT) for the characterization and confirmation of the species or taxa present
in herbal infusions. As a model plant for this protocol, Camellia sinensis, a traditional
tea plant, was selected due to the following reasons: its historical popularity as a (healthy)
beverage, its high selling value, the importation of barely recognizable raw product (i.e.,
crushed), and the scarcity of studies concerning adulterants or contamination. The DNA
Verity Test includes both the sequencing of DNA barcoding markers and genotyping of
labeled-PCR DNA barcoding fragments for each sample analyzed. This protocol (DVT) was
successively applied to verify the authenticity of 32 commercial teas (simple or admixture),
and the main results can be summarized as follows: (1) the DVT protocol is suitable to
detect adulteration in tea matrices (contaminations or absence of certified ingredients), and
the method can be exported for the study of other similar systems; (2) based on the BLAST
analysis of the sequences of rbcL+matK±rps7-trnV(GAC) chloroplast markers, C. sinensis
can be taxonomically characterized; (3) rps7-trnV(GAC) can be employed to discriminate
C. sinensis from C. pubicosta; (4) ITS2 is not an ideal DNA barcode for tea samples, reflecting
potential incomplete lineage sorting and hybridization/introgression phenomena in
C. sinensis taxa; (5) the genotyping approach is an easy, inexpensive and rapid pre-screening
method to detect anomalies in the tea templates using the trnH(GUG)-psbA barcoding
marker; (6) two herbal companies provided no authentic products with a contaminant or
without some of the listed ingredients; and (7) the leaf matrices present in some teabags
could be constituted using an admixture of different C. sinensis haplotypes and/or allied species
(C. pubicosta)
Correction: What is in your cup of tea? DNA Verity Test to characterize black and green commercial teas
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study
Abstract Background (Trans)-3,7-Dimethyl-2,6-octadien-1-ol, commonly called geraniol (Ge-OH), is an acyclic monoterpene alcohol with well-known anti-inflammatory and antimicrobial properties. Ge-OH is a non-toxic compound classified as Generally Recognized As Safe (GRAS) by the US Food and Drug Administration and the European Food Security Agency. Methods Ge-OH was orally administered at a maximum daily dose of 8 mg kg(− 1) body weight for four weeks in a delayed release formulation capable of reaching the colon. Fecal microbiota and blood cytokines were analyzed before and after Ge-OH treatment, as well as IBS symptomatology by using Visual Analogue Scale (VAS-IBS). Results The results show that orally administered Ge-OH is a powerful modulator of the intestinal microbial ecosystem, capable of leading to increased relative abundances of Collinsella and especially Faecalibacterium, a well-known health-promoting butyrate producer consistently found to be decreased in IBS patients. Moreover, Ge-OH strongly improved the clinical symptoms of colitis by significantly reducing the score recorded by the VAS-IBS questionnaire. Clinical improvement was associated with a significant reduction in the circulating MIP-1β, a chemokine found to be increased in several IBS patients. Conclusion Ge-OH could be a powerful component for food supplement targeted to the treatment of IBS patients. Trial registration ISRCTN47041881, retrospectively registered on 19th July 2018
Primers used in the present study for DNA barcoding analyses.
<p>Primers used in the present study for DNA barcoding analyses.</p
List of Italian commercialized black and green tea packages analyzed in the present study (N and V samples, respectively).
<p>Information for each accession about the marketing quality (high, medium and low), sales network (D = discount supermarket; H = herbalist shop; S = supermarket; P = drugstore), price (ϵ) {(A), < 1 ϵ; (B), 1 < ϵ < 2; (C), 2 < ϵ < 4; (D), 4 < ϵ < 6; (E), > 6 ϵ} and molecular results for <i>rbc</i>L and <i>rps</i>7-<i>trn</i>V<sup>(GAC)</sup> sequences (presence of a SNP in the 68 bp coding region of <i>rbc</i>L, A = adenine, C = cytosine; <i>rps</i>7-<i>trn</i>V<sup>(GAC)</sup>, 239 bp = <i>Camellia sinensis</i>, 226 bp = <i>C</i>. <i>pubicosta</i>; in smaller font, the nucleotide/fragment less represented).</p